Chromatin Engagement and Transcriptional Activity of the ZNF217 Exon 4–Skipping Isoform Are Associated with Breast Cancer Aggressiveness and Bone Metastasis
Pia Fahmé(Lyon 1 Université), Pascale A. Cohen(Lyon 1 Université), Lamia Bouazza(Lyon 1 Université), Philippe Clézardin(Université Claude Bernard Lyon 1), Séverine Croze(Lyon 1 Université), Joël LACHUER(Lyon 1 Université), Farah Ramadan(Université Claude Bernard Lyon 1), Mariapia Riso(Albert Einstein College of Medicine), Balázs Győrffy(Semmelweis University), Robert A. Coleman(Albert Einstein College of Medicine), Martine Croset(Université Claude Bernard Lyon 1), Justin Ferraro(Albert Einstein College of Medicine), Olivier Peyruchaud(Université Claude Bernard Lyon 1)
Cited by 0
Related Papers
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
|Endocrine Related Cancer|2006|239
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
|Recent Patents on Anti-Cancer Drug Discovery|2009|162
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways
|International Journal of Cancer|2009|131